Beilstein J. Org. Chem. 2012, 8, 606–612.
126.05, 84.05, 78.0, 52.8, 38.8, 24.8; IR (KBr) ν/cm−1: 2916 = 7.9, 7.3, 1.5 Hz, 1H), 3.87 (d, J = 17.8 Hz, 1H), 3.37 (d, J =
(w), 1761 (m), 1607 (w), 1392 (m), 1353 (st), 1325 (m), 1268 17.5 Hz, 1H), 3.20 (s, 3H), 1.36 (s, 9H), 1.32 (s, 12H);
(m), 1208 (m), 1140 (st); HRMS–EI (m/z): calcd for 13C NMR (CDCl3, 100 MHz) δ 156.4, 134.95, 132.3, 125.7,
C17H22BNO5, 331.1586; found, 331.1588.
83.95, 81.6, 39.8, 35.3, 31.6, 25.15, 24.8, 22.5, 13.95; IR (KBr)
ν/cm−1: 2929 (w), 1611 (w), 1397 (m), 1357 (st), 1323 (m),
tert-Butyl 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- 1268 (m), 1142 (st), 1091 (st), 858 (m); HRMS–EI (m/z): calcd
yl)phenyl)-4,5-dihydroisoxazole-5-carboxylate (7c): Isolated for C20H30BNO3, 343.2313; found, 343.2311.
as a white solid (105 mg, 56%) after purification by column
chromatography (10% Et2O in petroleum ether); 1H NMR 5-Methyl-5-phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxa-
(CDCl3, 400 MHz) δ 7.78 (d, J = 8.2 Hz, 2H), 7.64 (d, J = 8.2 borolan-2-yl)phenyl)-4,5-dihydroisoxazole (7g): Isolated as a
Hz, 2H), 5.03 (t, J = 9.4 Hz, 1H), 3.56 (d, J = 9.4 Hz, 2H), 1.47 colourless oil (88 mg, 48%) after purification by column chro-
(s, 9H), 1.32 (s, 12H); 13C NMR (CDCl3, 100 MHz) δ 169.25, matography (10% Et2O in petroleum ether, Rf 0.54, 50% Et2O
156.1, 135.2, 131.3, 126.2, 84.2, 82.9, 79.0, 38.8, 28.1, 25.0; IR in petroleum ether); 1H NMR (CDCl3, 400 MHz) δ 7.80 (d, J =
(KBr) ν/cm−1: 2966 (m), 1742 (m), 1726 (m), 1611 (w), 1390 8.3 Hz, 2H), 7.63 (d, J = 8.3 Hz, 2H), 7.47 (m, 2H), 7.35 (m,
(m), 1356 (st), 1323 (m), 1142 (st); HRMS–EI (m/z): calcd for 2H), 7.27 (m, 1H), 3.49 (AB quartet, J = 16.5 Hz, 2H), 1.79 (s,
C20H28BNO5, 373.2055; found, 373.2048.
3H), 1.33 (s, 12H); 13C NMR (CDCl3, 100 MHz) δ 156.4,
145.6, 135.2, 132.4, 128.7, 127.5, 125.9, 124.8, 88.4, 84.2, 48.8,
N,N-dimethyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan- 28.5, 25.0; HRMS–EI (m/z): calcd for C22H26BNO3, 363.2000;
2-yl)phenyl)-4,5-dihydroisoxazole-5-carboxamide (7d): found, 363.1979.
Isolated as a colourless oil (85 mg, 49%) after purification by
column chromatography (80% Et2O in petroleum ether, Rf 0.43, 4-Methyl-5-phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxa-
50% Et2O in petroleum ether); 1H NMR (CDCl3, 400 MHz) δ borolan-2-yl)phenyl)-4,5-dihydroisoxazole (7ha) and
7.82 (d, J = 8.3 Hz, 2H), 7.67 (d, J = 8.2 Hz, 2H), 5.38 (dd, J = 5-methyl-4-phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxa-
11.2, 7.7 Hz, 1H), 4.19 (dd, J = 16.8, 7.7 Hz, 1H), 3.38 (dd, J = borolan-2-yl)phenyl)-4,5-dihydroisoxazole (7hb): Isolated as
16.8, 11.3 Hz, 1H), 3.21 (s, 3H), 3.00 (s, 3H), 1.34 (s, 12H); a colourless oil (65 mg, 36%) after purification by column chro-
13C NMR (CDCl3, 100 MHz) δ 167.2, 157.4, 135.0, 131.3, matography (10% Et2O in petroleum ether, Rf 0.57, 50% Et2O
126.0, 84.0, 78.3, 37.3, 36.8, 36.1, 24.8; IR (KBr) ν/cm−1: 2966 in petroleum ether) to give an inseparable 2:1 mixture of regio-
(m), 1742 (m), 1726 (m), 1611 (w), 1390 (m), 1356 (st), 1323 isomers a and b; 1H NMR (CDCl3, 400 MHz) regioisomer a, δ
(m), 1142 (st); HRMS–EI (m/z): calcd for C18H25BN2O4, 7.84 (d, J = 8.3 Hz, 2H), 7.66 (d, J = 8.3 Hz, 2H), 7.39–7.28 (m,
344.1902; found, 344.1899.
5H), 5.31 (d, J = 5.6 Hz, 1H), 3.70 (dq, J = 7.1, 5.7 Hz, 1H),
1.45 (d, J = 7.1 Hz, 3H), 1.35 (s, 12H); 1H NMR (CDCl3, 400
Methyl 5-methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxa- MHz) regioisomer b, δ 7.70 (d, J = 8.3 Hz, 2H), 7.56 (d, J = 8.3
borolan-2-yl)phenyl)-4,5-dihydroisoxazole-5-carboxylate Hz, 2H), 7.25–7.19 (m, 5H), 4.66 (apparent qn, J = 6.3 Hz, 1H),
(7e): Isolated as a pale yellow oil (141 mg, 82%) after purifica- 4.33 (d, J = 6.0 Hz, 1H), 1.49 (d, J = 6.3 Hz, 3H), 1.31 (s, 12H);
tion by column chromatography (15% Et2O in petroleum ether, 13C NMR (CDCl3, 100 MHz) resonances that could be assigned
Rf 0.36, 50% Et2O in petroleum ether); 1H NMR (CDCl3, 400 to specific regioisomers by using proton–carbon 2D correlation
MHz) δ 7.81 (d, J = 8.1 Hz, 2H), 7.63 (d, J = 8.2 Hz, 2H), 3.88 spectroscopy are designated a or b, δ 160.2, 158.1, 140.8, 139.0,
(d, J = 17.0 Hz, 1H), 3.79 (s, 3H), 3.21 (d, J = 17.0 Hz, 1H), 135.1, 134.8, 131.5, 131.2, 130.4, 129.2, 128.7, 128.1, 127.6,
1.70 (s, 3H), 1.33 (s, 12H); 13C NMR (CDCl3, 100 MHz) δ 127.45, 126.3, 126.2, 125.4, 90.15a, 86.95b, 84.0, 83.9, 61.0b,
172.5, 156.3, 135.0, 131.3, 125.85, 86.2, 84.0, 53.0, 44.65, 24.8, 50.75a, 24.8, 24.75, 20.5b, 18.2a; HRMS–EI (m/z): calcd for
23.6; IR (KBr) ν/cm−1: 2975 (w), 1744 (m), 1609 (w), 1516 C22H26BNO3, 363.2000; found, 363.1988.
(w), 1394 (m), 1349 (st), 1326 (st), 1268 (m), 1146 (st);
HRMS–EI (m/z): calcd for C18H24BNO5, 345.1742; found, 5-(4-Bromophenyl)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxa-
345.1740.
borolan-2-yl)phenyl)-4,5-dihydroisoxazole (7i): Isolated as a
white solid (152 mg, 71%) after purification by column chroma-
5-Pentyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2- tography (10% Et2O in petroleum ether, Rf 0.35, 50% Et2O in
yl)phenyl)-4,5-dihydroisoxazole (7f): Isolated as a colourless petroleum ether); 1H NMR (CDCl3, 400 MHz) δ 7.82 (d, J =
oil (61 mg, 36%) after purification by column chromatography 8.3 Hz, 2H), 7.65 (d, J = 8.3 Hz, 2H), 7.48 (d, J = 8.5 Hz, 2H),
(20% Et2O in petroleum ether, Rf 0.40, 50% Et2O in petroleum 7.26 (d, J = 8.5 Hz, 2H), 5.68 (dd, J = 11.0, 8.2 Hz, 1H), 3.77
ether); 1H NMR (CDCl3, 400 MHz) δ 8.32 (d, J = 8.3 Hz, 2H), (dd, J = 16.7, 11.1 Hz, 1H), 3.28 (dd, J = 16.7, 8.2 Hz, 1H),
7.50 (m, 4H), 7.31 (ddd, J = 8.2, 7.2, 1.6 Hz, 1H), 7.19 (ddd, J 1.33 (s, 12H); 13C NMR (CDCl3, 400 MHz) δ 156.1, 139.9,
610